[HTML][HTML] Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis

LN Moore, DL Holmes, A Sharma… - PLoS …, 2023 - journals.plos.org
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

[PDF][PDF] Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis

LN Moore, DL Holmes, A Sharma… - PLoS …, 2023 - pdfs.semanticscholar.org
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis.

LN Moore, DL Holmes, A Sharma, M Lagunoff - Plos Pathogens, 2023 - europepmc.org
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis

L Moore - 2023 - digital.lib.washington.edu
Kaposi's Sarcoma Herpesvirus (KSHV) is an oncogenic gammaherpesvirus that, like other
herpesviruses, can establish both lytic and latent replication programs. It is the etiologic …

[HTML][HTML] Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis

LN Moore, DL Holmes, A Sharma, JL Vinueza… - PLOS …, 2023 - ncbi.nlm.nih.gov
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis

LN Moore, DL Holmes, A Sharma… - PLoS …, 2023 - pubmed.ncbi.nlm.nih.gov
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis.

LN Moore, DL Holmes, A Sharma, JL Vinueza… - PLoS …, 2023 - agris.fao.org
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis.

LN Moore, DL Holmes, A Sharma… - PLoS …, 2023 - search.ebscohost.com
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …

Bcl-xL Is Required to Protect Endothelial Cells Latently Infected With KSHV From Virus Induced Intrinsic Apoptosis

L Moore - 2023 - search.proquest.com
Abstract Kaposi's Sarcoma Herpesvirus (KSHV) is an oncogenic gammaherpesvirus that,
like other herpesviruses, can establish both lytic and latent replication programs. It is the …

Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis

DL Holmes, A Sharma, JL Vinueza - PLoS Pathogens, 2023 - search.proquest.com
Kaposi's Sarcoma herpesvirus (KSHV) is the etiologic agent of Kaposi's Sarcoma (KS), a
highly vascularized tumor common in AIDS patients and many countries in Africa. KSHV is …